The director general of the World Health Organization (WHO) said it must immediately get the results of clinical trials of drugs that are considered effective in treating patients with the Corona COVID-19 virus. The Solidarity Trial is divided into five sections looking at possible treatment approaches for the Corona COVID-19 virus
Drugs that are being tested, such as remdesivir, hydroxychloroquine malaria drug, HIV drugs lopinavir or ritonavir and lopinavir or ritonavir combined with interferon. However, earlier this month, the WHO stopped the hydroxychloroquine trial after research showed no benefit to those who had the Coronavirus using this drug, but there was still much further research to see if it was effective as a drug to prevent Corona.
“Nearly 5,500 patients in 39 countries have so far been recruited into the Solidarity Trial,” director general Tedros Adhanom Ghebreyesus said at a news briefing in Geneva, referring to clinical studies conducted by the UN agency, quoted from ABC News.
“We expect interim results in the next two weeks,” Tedros continued
Mike Ryan, head of the WHO emergency program, said it was not wise to predict when the vaccine could be ready immediately against the Corona COVID-19 virus. respiratory disease caused by the Corona virus has just killed more than half a million people.
While the vaccine candidates are said to be likely to show effectiveness at the end of the year. He told reporters at the briefing that the question was how quickly it could be mass produced.
“At present there is no vaccine that is proven against this disease, but 18 potential candidates are being tested in humans,” Ryan said.
“I am sorry that there is no fair and accessible access to the COVID tool. I regret that some countries have more than others, and I am sorry that frontline workers have died of the Corona COVID-19 virus,” he said.
Ryan urged countries to continue identifying new Corona case groups, tracking infected people, and isolating them to help break the transmission chain.